Detalles de la búsqueda
1.
Hepatic Arterial Infusion Chemotherapy with Oxaliplatin Plus Raltitrexed as an Alternative Option in Advanced Hepatocellular Carcinoma Patients with Failure of, or Unsuitability for, Transarterial Chemoembolization.
Medicina (Kaunas)
; 58(10)2022 Sep 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-36295504
2.
Recurrence Outcome in Hepatocellular Carcinoma within Milan Criteria Undergoing Microwave Ablation with or without Transarterial Chemoembolization.
Medicina (Kaunas)
; 58(8)2022 Jul 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-36013483
3.
S100A11 promotes cell proliferation via P38/MAPK signaling pathway in intrahepatic cholangiocarcinoma.
Mol Carcinog
; 58(1): 19-30, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30182496
4.
Overexpression of interleukin-35 in intrahepatic cholangiocarcinoma is a prognostic indicator after curative resection.
Cancer Sci
; 109(4): 1195-1206, 2018 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-29446854
5.
Prognostic Nomogram Based on Histological Characteristics of Fibrotic Tumor Stroma in Patients Who Underwent Curative Resection for Intrahepatic Cholangiocarcinoma.
Oncologist
; 23(12): 1482-1493, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30257891
6.
RA190, a Proteasome Subunit ADRM1 Inhibitor, Suppresses Intrahepatic Cholangiocarcinoma by Inducing NF-KB-Mediated Cell Apoptosis.
Cell Physiol Biochem
; 47(3): 1152-1166, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29913454
7.
S100A11 promotes TGF-ß1-induced epithelial-mesenchymal transition through SMAD2/3 signaling pathway in intrahepatic cholangiocarcinoma.
Future Oncol
; 14(9): 837-847, 2018 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-29569474
8.
S100A6 promotes proliferation of intrahepatic cholangiocarcinoma cells via the activation of the p38/MAPK pathway.
Future Oncol
; 13(23): 2053-2063, 2017 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-28984474
9.
Pten Deletion Promotes Regrowth of Corticospinal Tract Axons 1 Year after Spinal Cord Injury.
J Neurosci
; 35(26): 9754-63, 2015 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26134657
10.
CBX1 is involved in hepatocellular carcinoma progression and resistance to sorafenib and lenvatinib via IGF-1R/AKT/SNAIL signaling pathway.
Hepatol Int
; 2024 May 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38769286
11.
A novel myeloid cell marker genes related signature can indicate immune infiltration and predict prognosis of hepatocellular carcinoma: Integrated analysis of bulk and single-cell RNA sequencing.
Front Mol Biosci
; 10: 1118377, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36959981
12.
Tumor Radiomic Features on Pretreatment MRI to Predict Response to Lenvatinib plus an Anti-PD-1 Antibody in Advanced Hepatocellular Carcinoma: A Multicenter Study.
Liver Cancer
; 12(3): 262-276, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37601982
13.
Efficacy of Transarterial Chemoembolization Combined with Molecular Targeted Agents for Unresectable Hepatocellular Carcinoma: A Network Meta-Analysis.
Cancers (Basel)
; 14(15)2022 Jul 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-35954373
14.
Comprehensive Analysis of the Prognosis and Correlations With Immune Infiltration of S100 Protein Family Members in Hepatocellular Carcinoma.
Front Genet
; 12: 648156, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33815482
15.
Identification of a Pyroptosis-Related Gene Signature for Predicting Overall Survival and Response to Immunotherapy in Hepatocellular Carcinoma.
Front Genet
; 12: 789296, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34925465
16.
Hepatic stellate cells promote intrahepatic cholangiocarcinoma progression via NR4A2/osteopontin/Wnt signaling axis.
Oncogene
; 40(16): 2910-2922, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33742120
17.
Comparative performance of inflammation-based prognostic scores in patients operated for intrahepatic cholangiocarcinoma.
Cancer Manag Res
; 11: 9107-9119, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31802940
18.
High expression of Oct4 and Nanog predict poor prognosis in intrahepatic cholangiocarcinoma patients after curative resection.
J Cancer
; 10(5): 1313-1324, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30854141
19.
HHLA2 in intrahepatic cholangiocarcinoma: an immune checkpoint with prognostic significance and wider expression compared with PD-L1.
J Immunother Cancer
; 7(1): 77, 2019 03 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-30885276
20.
Treatment with the herbal formula Songyou Yin inhibits epithelial-mesenchymal transition in hepatocellular carcinoma through downregulation of TGF-ß1 expression and inhibition of the SMAD2/3 signaling pathway.
Oncol Lett
; 13(4): 2309-2315, 2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-28454396